Authors:
Chassevent, A
Jourdan, ML
Romain, S
Descotes, F
Colonna, M
Martin, PM
Bolla, M
Spyratos, F
Citation: A. Chassevent et al., S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: A standardizedflow cytometric study, CLIN CANC R, 7(4), 2001, pp. 909-917
Authors:
Accomazzo, MR
Rovati, GE
Vigano, T
Hernandez, A
Bonazzi, A
Bolla, M
Fumagalli, F
Viappiani, S
Galbiati, E
Ravasi, S
Albertoni, C
Di Luca, M
Caputi, A
Zannini, P
Chiesa, G
Villa, AM
Doglia, SM
Folco, G
Nicosia, S
Citation: Mr. Accomazzo et al., Leukotriene D-4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent, AM J R CRIT, 163(1), 2001, pp. 266-272
Authors:
Neymark, N
Adriaenssen, I
Gorlia, T
Caleo, S
Bolla, M
Brochon, D
Citation: N. Neymark et al., Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis, EUR J CANC, 37(14), 2001, pp. 1768-1774
Authors:
Lavagnini, P
Cartei, F
Princivalle, S
Bolla, M
Collette, L
Zurlo, A
de Reijke, T
Ash, D
Batterman, J
Blank, L
Citation: P. Lavagnini et al., Development of a joint (ESTRO-EAU-EORTC) survey of early prostate cancer treatment status update, TUMORI, 87(4), 2001, pp. S135-S135
Authors:
Humphries, SE
Talmud, PJ
Hawe, E
Bolla, M
Day, INM
Miller, GJ
Citation: Se. Humphries et al., Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke:a prospective study, LANCET, 358(9276), 2001, pp. 115-119
Authors:
Bonazzi, A
Bolla, M
Buccellati, C
Hernandez, A
Zarini, S
Vigano, T
Fumagalli, F
Viappiani, S
Ravasi, S
Zannini, P
Chiesa, G
Folco, G
Sala, A
Citation: A. Bonazzi et al., Effect of endogenous and exogenous prostaglandin E-2 on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cells, AM J R CRIT, 162(6), 2000, pp. 2272-2277
Authors:
Bentzen, SM
Bernier, J
Davis, JB
Horiot, JC
Garavaglia, G
Chavaudra, J
Johansson, KA
Bolla, M
Citation: Sm. Bentzen et al., Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study ofthe European Organization for Research and Treatment of Cancer, EUR J CANC, 36(5), 2000, pp. 615-620
Authors:
Hugli, A
Moro, D
Mermillod, B
Bolla, M
Alberto, P
Bonnefoi, H
Miralbell, R
Citation: A. Hugli et al., Phase II trial of up-front accelerated thoracic radiotherapy combined withchemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer, J CL ONCOL, 18(8), 2000, pp. 1662-1667
Authors:
Horiot, JC
Lipinski, F
Schraub, S
Maulard-Durdux, C
Bensadoun, RJ
Ardiet, JM
Bolla, M
Coscas, Y
Baillet, F
Coche-Dequeant, B
Urbajtel, M
Montbarbon, X
Bourdin, S
Wibault, P
Alfonsi, M
Calais, G
Desprez, P
Pene, F
Lapeyre, M
Vinke, J
Maral, J
Citation: Jc. Horiot et al., Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study, RADIOTH ONC, 55(3), 2000, pp. 233-239
Authors:
Bertrand, MF
Leforestier, E
Muller, M
Lupi-Pegurier, K
Bolla, M
Citation: Mf. Bertrand et al., Effect of surface penetrating sealant on surface texture and microhardnessof composite resins, J BIOMED MR, 53(6), 2000, pp. 658-663
Authors:
Romain, S
Spyratos, F
Descotes, F
Daver, A
Rostaing-Puissant, B
Bougnoux, P
Colonna, M
Bolla, M
Martin, PM
Citation: S. Romain et al., Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: A retrospective multicenter study, INT J CANC, 87(6), 2000, pp. 860-868
Authors:
Exbrayat, C
Garnier, A
Colonna, M
Assouline, D
Salicru, B
Winckel, P
Menegoz, F
Bolla, M
Citation: C. Exbrayat et al., Analysis and classification of interval cancers in a French breast cancer screening programme (departement of Isere), EUR J CAN P, 8(3), 1999, pp. 255-260
Authors:
Miralbell, R
Mornex, F
Greiner, R
Bolla, M
Storme, G
Hulshof, M
Bernier, J
Denekamp, J
Rojas, AM
Pierart, M
van Glabbeke, M
Mirimanoff, RO
Citation: R. Miralbell et al., Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: Report of European organization for research and treatment of cancertrial 22933, J CL ONCOL, 17(10), 1999, pp. 3143-3149
Citation: M. Pavone-macaluso,"bolla et M. Zerbib, Adjuvant hormonal treatment with radiotherapy for locally advanced prostate cancer - Discussion, EUR UROL, 35, 1999, pp. 26-26
Authors:
Agradi, E
Brevini, TAL
Bolla, M
Baga, R
Favetta, LA
Citation: E. Agradi et al., Cytochrome P-450 levels and EROD activity in the Adriatic sturgeon (Acipenser naccarii, Chondrostei) and its induction by beta-Naphthoflavone, J APP ICHTH, 15(4-5), 1999, pp. 96-98
Authors:
Bolla, M
de Cornulier, J
Berland, E
Colonna, M
Artignan, X
Pasquier, D
Salvat, J
Chirpaz, E
Garnier, C
Citation: M. Bolla et al., Pathological prognostic factors in a series of 137 stage I TNM/UICC endometrial carcinomas, RADIOTH ONC, 53(3), 1999, pp. 209-211
Authors:
Spyratos, F
Romain, S
Rostaing-Puissant, B
Daver, A
Colonna, M
Descotes, F
Martin, PM
Bougnoux, P
Roth, H
Bolla, M
Citation: F. Spyratos et al., Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study 1. DNA synthesis enzyme activities, B CANCER, 86(7-8), 1999, pp. 678-684